News Item

Rupprecht Consult signed the Manifesto for EU COVID-19 research

The European Commission set up a Manifesto with the aim of maximising the accessibility of research results in the fight against COVID-19.

The Manifesto is part of the EU Coronavirus response, the common European response to the coronavirus outbreak. It provides guiding principles for beneficiaries of EU research grants for coronavirus prevention, testing, treatment and vaccination to ensure that their research results will be accessible for all and guarantee a return on public investment. This will aim to ensure that no one is left behind in the fight against Covid-19, and that solutions will be developed, produced and deployed to every single corner of the world. The Manifesto seeks the voluntary support and endorsement from public and private stakeholders benefitting from EU funding, as well as from other research funders and prominent institutions. The Commission is proud of the support received so far (you can find an updated list of organisations that already endorsed the Manifesto <link https: ec.europa.eu info research-and-innovation research-area health-research-and-innovation coronavirus-research-and-innovation covid-research-manifesto_en external-link-new-window external link in new>here). By signing, we agreed to and endorsed the principles below when dealing with research results stemming from EU funded research grants related to COVID-19 on prevention, testing, treatment and vaccination:

1. Make the generated results, whether tangible or intangible, public and accessible without delay, for instance on the Horizon Results Platform, on an existing IP sharing platform, or through an existing patent pool;
2. Make scientific papers and research data available in open access without delay and following the FAIR principles via preprint servers or public repositories, with rights for others to build upon the publications and data and with access to the tools needed for their validation. Specifically for COVID-19 research data, make them available through the European COVID-19 Data Platform;
3. Where possible, grant limited time, non-exclusive royalty free licences for the intellectual property. These non-exclusive royalty free licenses will be given in exchange for the licensees’ commitment to rapidly and broadly distribute the resulting products and services under fair and reasonable conditions to prevent, diagnose, treat and contain Covid-19.

Feel free to join Rupprecht Consult and the other signatories!<link https: ec.europa.eu eusurvey runner covid-19-research-results-manifesto external-link-new-window external link in new>ec.europa.eu/eusurvey/runner/covid-19-research-results-manifesto

Further Information